Hostname: page-component-586b7cd67f-tf8b9 Total loading time: 0 Render date: 2024-11-28T03:19:33.930Z Has data issue: false hasContentIssue false
  • English
  • Français

Comorbidities and treatment of somatoform disorders before switching to DSM-5 and ICD-11: what to consider

Published online by Cambridge University Press:  01 September 2022

R. Marinescu  and
M. Fadgyas Stanculete
R. Marinescu*
Affiliation:
Iuliu Hatieganu University of Medicine and Pharmacy Cluj-Napoca, Department Of Neurosciences - Psychiatry, Cluj-Napoca, Romania Cluj County Emergency Hospital, 2nd Psychiatric Clinic, Cluj-Napoca, Romania
M. Fadgyas Stanculete
Affiliation:
Iuliu Hatieganu University of Medicine and Pharmacy Cluj-Napoca, Department Of Neurosciences - Psychiatry, Cluj-Napoca, Romania Cluj County Emergency Hospital, 2nd Psychiatric Clinic, Cluj-Napoca, Romania
*
*Corresponding author.

Abstract

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the ‘Save PDF’ action button.
Introduction

Somatoform disorders, previously diagnosed according to DSM-IV-TR and ICD-10, are shifting towards somatic symptom disorder in DSM-V and bodily distress disorder in ICD-11.

Objectives

Before using the current criteria, because the new diagnostic entities can identify a larger pool of patients with various physical complaints and diagnoses, it is essential to consider the physical and psychiatric comorbidities that have an important role in deciding the pharmacological treatment.

Methods

We conducted a retrospective observational study on a group of 169 patients previously diagnosed with a type of somatoform disorder and hospitalized between January 2015 - January 2021 in a psychiatric emergency hospital in Cluj-Napoca, Romania.

Results

Male:female ratio was 1:1.41. The mean age was 52.35±13.3 years, the mean period of hospitalization was 12±5.39 days. 54% of patients lived in urban areas, and almost half of them were married. Most patients were not professionally active and did not receive a superior education. Most patients had one hospitalization and had at least one physical and one psychiatric comorbidity. The most frequent somatic comorbidities were: cardiovascular, metabolic, rheumatological, gastrointestinal, endocrinological, and neurological, and the most frequent psychiatric ones were: depressive, personality, anxiety, neurocognitive, and substance use disorders. The most frequent type of somatoform disorders were: undifferentiated somatoform disorder and somatization disorder. Regarding psychiatric treatment, antidepressants, antipsychotics, benzodiazepines, anticonvulsants, and hypnotics were used. No correlations were observed between the presence of depressive or anxiety disorders and somatic comorbidities.

Conclusions

ICD and DSM need to clarify diagnostic criteria and develop therapeutical guidelines for this type of patient.

Disclosure

No significant relationships.

Keywords

somatoformcomorbiditiesTreatment
Type
Abstract
Information
European Psychiatry , Volume 65 , Special Issue S1: Abstracts of the 30th European Congress of Psychiatry , June 2022 , pp. S188 - S189
Creative Commons
Creative Common License - CCCreative Common License - BY
This is an Open Access article, distributed under the terms of the Creative Commons Attribution licence (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted re-use, distribution, and reproduction in any medium, provided the original work is properly cited.
Copyright
© The Author(s), 2022. Published by Cambridge University Press on behalf of the European Psychiatric Association
Submit a response

Comments

No Comments have been published for this article.